Teleflex Incorporated (NYSE:TFX) Shares Bought by LPL Financial LLC

LPL Financial LLC grew its position in Teleflex Incorporated (NYSE:TFX) by 36.4% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 34,931 shares of the medical technology company’s stock after acquiring an additional 9,330 shares during the period. LPL Financial LLC’s holdings in Teleflex were worth $6,217,000 at the end of the most recent quarter.

Several other hedge funds have also modified their holdings of the company. KLP Kapitalforvaltning AS acquired a new position in Teleflex in the 4th quarter worth about $2,634,000. Sei Investments Co. raised its stake in shares of Teleflex by 23.8% during the 4th quarter. Sei Investments Co. now owns 102,611 shares of the medical technology company’s stock worth $18,263,000 after buying an additional 19,707 shares during the period. American Century Companies Inc. raised its stake in shares of Teleflex by 1,277.0% during the 4th quarter. American Century Companies Inc. now owns 136,955 shares of the medical technology company’s stock worth $24,376,000 after buying an additional 127,009 shares during the period. Quantbot Technologies LP purchased a new position in shares of Teleflex during the 4th quarter valued at approximately $5,021,000. Finally, Goodman Financial Corp acquired a new stake in Teleflex in the 4th quarter valued at $13,378,000. 95.62% of the stock is owned by hedge funds and other institutional investors.

Teleflex Price Performance

TFX stock opened at $130.95 on Tuesday. Teleflex Incorporated has a 1 year low of $127.18 and a 1 year high of $249.91. The company has a debt-to-equity ratio of 0.37, a current ratio of 2.42 and a quick ratio of 1.39. The firm has a market capitalization of $6.07 billion, a PE ratio of 26.03, a price-to-earnings-growth ratio of 1.73 and a beta of 1.19. The business has a 50 day simple moving average of $153.81 and a 200-day simple moving average of $185.45.

Teleflex (NYSE:TFX) last issued its earnings results on Thursday, February 27th. The medical technology company reported $3.89 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.86 by $0.03. Teleflex had a return on equity of 14.19% and a net margin of 7.85%. The company had revenue of $795.40 million during the quarter, compared to analysts’ expectations of $813.24 million. Equities research analysts anticipate that Teleflex Incorporated will post 13.98 earnings per share for the current fiscal year.

Teleflex Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Monday, March 17th. Investors of record on Friday, March 7th were given a dividend of $0.34 per share. This represents a $1.36 annualized dividend and a yield of 1.04%. The ex-dividend date of this dividend was Friday, March 7th. Teleflex’s payout ratio is currently 95.77%.

Wall Street Analysts Forecast Growth

TFX has been the subject of a number of research analyst reports. Piper Sandler restated a “neutral” rating and set a $140.00 price objective (down from $255.00) on shares of Teleflex in a research report on Friday, February 28th. Raymond James downgraded shares of Teleflex from an “outperform” rating to a “market perform” rating in a research report on Friday, February 28th. Bank of America cut Teleflex from a “neutral” rating to an “underperform” rating and lowered their price objective for the stock from $235.00 to $140.00 in a report on Tuesday, March 4th. Royal Bank of Canada cut Teleflex from an “outperform” rating to a “sector perform” rating and reduced their target price for the company from $220.00 to $155.00 in a report on Friday, February 28th. Finally, Citizens Jmp lowered Teleflex from an “outperform” rating to a “market perform” rating in a research note on Thursday, February 27th. One research analyst has rated the stock with a sell rating, nine have issued a hold rating and two have given a buy rating to the company. Based on data from MarketBeat, Teleflex presently has a consensus rating of “Hold” and a consensus target price of $182.63.

Teleflex Company Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.